ViCentra raised €73M in a Series D+ round in Sep 2025. The company is based in Utrecht, Netherlands. Investors in the round: EQT Life Sciences, Health Innovations, Innovation Industries and 2 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
